![Douglas Manion](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Manion
Chairman at
LAKEWOOD
Net worth: 22 901 $ as of 31/05/2026
Profile
Douglas J.
Manion is Chief Executive Officer & Director at Flare Therapeutics, Inc. since 2024.
He is Chairman at Lakewood-Amedex Biotherapeutics, Inc. and Lakewood-Amedex, Inc., both since 2021.
Formerly, Dr. Manion was President, Chief Executive Officer & Director at Aclaris Therapeutics, Inc. from 2023 to 2024.
He was Chairman & Chief Executive Officer at Kleo Pharmaceuticals, Inc. from 2020 to 2021.
He served as Non-Executive Director at Celleron Therapeutics Ltd. He was Senior VP & Head-Specialty Development at Bristol Myers Squibb Co. from 2014 to 2016.
He was Executive Vice President-Research & Development at Arena Pharmaceuticals, Inc. from 2021 to 2022.
He was VP-Clinical Development & Medical Affairs at GSK Plc from 2001 to 2005.
Education includes undergraduate and doctorate degrees from the University of Ottawa.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/04/2026 | 33,928 ( 0.48% ) | 22 901 $ | 31/05/2026 |
Douglas Manion active positions
| Companies | Position | Start |
|---|---|---|
| LAKEWOOD | Chairman | 12/02/2025 |
Lakewood-Amedex, Inc.
 Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Chairman | 13/02/2025 |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Chief Executive Officer | 23/04/2024 |
Former positions of Douglas Manion
| Companies | Position | End |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Chief Executive Officer | 16/01/2024 |
| ARENA PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 01/03/2022 |
Kleo Pharmaceuticals, Inc.
 Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Chief Executive Officer | 31/01/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 19/02/2013 |
| GSK PLC | Corporate Officer/Principal | 01/01/2005 |
Training of Douglas Manion
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Ottawa
 University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amedex Therapeutics, Inc.
 Amedex Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel antimicrobial therapeutics | Health Technology |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Health Technology |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Commercial Services |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
- Stock Market
- Insiders
- Douglas Manion
